The New England Journal of Medicine
HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   HELP   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
THIS WEEK
August 24, 2000
in the New England Journal of Medicine

 


Estrogen Replacement and Coronary-Artery Atherosclerosis
Observational studies suggest that postmenopausal estrogen-replacement therapy reduces the risk of cardiovascular events, although the recent Heart and Estrogen/Progestin Replacement Study has called this conclusion into question with respect to women with known coronary artery disease. This current randomized study found no effect of either estrogen alone or estrogen plus progestin on the progression of established coronary lesions as assessed by quantitative methods over 3.2 years of follow-up.

Trends in the Incidence of Coronary Disease and Changes in Diet and Lifestyle in Women
This study of nearly 86,000 nurses found that the incidence of coronary heart disease declined by 31 percent between 1980 and 1994. Two thirds of the decline could be explained by a reduction in smoking, improvements in diet, and an increase in the use of postmenopausal hormone-replacement therapy. An increase in obesity, however, slowed the trend.

Siblings, Day Care, and the Risk of Asthma in Children
Among children followed from birth to 13 years of age, the incidence of asthma and frequent wheezing episodes between the ages of 6 and 13 years was lower among those who attended day care during the first 6 months of life and those who had one or more older siblings at home than among those without such exposure. A possible explanation for these findings is that children with more exposure to other children may have more infections, which in some way protect against asthma.

Hemoglobin H Disease in Hong Kong
graphIn hemoglobin H disease, a common hemoglobinopathy in China and Southeast Asia, two of the four a-globin genes are deleted and a third is deleted or mutated. In this study, most patients in Hong Kong who had hemoglobin H disease had deletions of three of the four a-globin genes. They had milder disease than patients in whom the third a-globin gene was mutated. Iron overload, a frequent and potentially serious complication of hemoglobin H disease, was independent of the type of genetic abnormality. Hence, the types of abnormalities of a-globin genes in hemoglobin H disease cannot account for all of its clinical variations.

Treatment of Type II Gastric Carcinoid Tumors

Type II gastric carcinoid tumors are rare tumors that develop in patients with both multiple endocrine neoplasia type 1 and the Zollinger­Ellison syndrome. This report describes the treatment of three photograph such patients with somatostatin analogues. After one year of treatment, the tumors were no longer visible on endoscopy and serum gastrin levels were markedly decreased. This treatment may provide an alternative to surgery or endoscopic therapy.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.